Re-Treating Lung Cancer with Radiotherapy Is Effective
By MedImaging International staff writers Posted on 21 May 2014 |
An old concept of re-treating lung tumors with radiation is now being reevaluated, particularly with the latest technologic developments experienced in radiation oncology over the last10 years.
The Comprehensive Cancer Center of Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) is one of only several cancer centers in the United States that is attempting to give lung cancer patients out of treatment alternatives to keep the cancer from reappearing. For these patients, hope lies in a second course of treatment--repeat radiation. Two complementary articles published in the March 2014 issue of the journal Radiotherapy and Oncology and the April 2014 issue of the Journal of Thoracic Oncology described the treatment success at Wake Forest Baptist.
“One of the toughest challenges of lung cancer is what to do for patients when the cancer comes back in an area that’s been treated previously with radiation treatment,” said James J. Urbanic, MD, lead author of the studies and a radiation oncologist at Wake Forest Baptist. “With some of the technological advances in radiation treatments that have occurred in the last 5 to 10 years, we’re beginning to re-look at the issue and ask—can we target the radiation precisely enough and with a high enough dose to knock the cancer back?”
According to Dr. Urbanic, the overall findings of the study suggest that there are some patients with recurrent lung tumors who can be treated with another definitive course of radiation therapy and still have a probability of a cure. “At many cancer treatment centers, these patients only get chemotherapy and have no chance at definitive treatment. The goal of treatment is solely to prevent or delay symptoms from developing and they are seen as incurable,” he said. “But with re-irradiation, our study shows that maybe we can give a curative intent treatment that we couldn’t do in the past. It’s a layer of hope for some patients that they never had before.”
The researchers reviewed 11 years of clinical research for the study. Eighty-six patients were identified who received at least two sequences of thoracic radiotherapy. Of that number, 33 were treated with repeat thoracic radiotherapy using stereotactic body radiation therapy (SBRT) or accelerated hypofractionated radiotherapy (AHRT), as a component of their treatment. The median age was 66 and the majority of patients (88%) were treated for primary lung cancer. The median tumor size at retreatment was 2.5 cm. Earlier lung resections had been performed in 24% of patients.
Dr. Urbanic noted that the typical patient is an older man or woman who got treated with either chemotherapy and radiation or radiation by itself for a lung cancer that could not be surgically removed. They have returned for a checkup and feel well, but a computed tomography (CT) scan shows that the cancer has returned in the area earlier treated. If the cancer is just in one area, the patients get retreated with 10 radiation treatments done with the SBRT technique which is tightly targeted to just the tumor and minimizes the dose to the neighboring healthy tissue.
“Wake Forest Baptist has been developing expertise in doing this,” Dr. Urbanic said. “We’re finding that there are patients who are alive years later. We have seen relatively modest toxicity and a good ability to try and control the disease upwards of 70% of the time.”
However, there is a higher risk of injury involved when someone is radiated a second time which is why other cancer treatment center programs might be reluctant to adopt the practice, Dr. Urbanic reported. “This is a fairly niche effort in lung cancer care, and we’d like to see a national level clinical trial at some point,” Dr. Urbanic said. “The technology has gotten to the point where I think it’s going to allow radiation oncologists to reassess their ability so that maybe they can take risks they weren’t willing to take before. Eventually, this practice will become more widespread.”
Related Links:
Comprehensive Cancer Center of Wake Forest Baptist Medical Center
The Comprehensive Cancer Center of Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) is one of only several cancer centers in the United States that is attempting to give lung cancer patients out of treatment alternatives to keep the cancer from reappearing. For these patients, hope lies in a second course of treatment--repeat radiation. Two complementary articles published in the March 2014 issue of the journal Radiotherapy and Oncology and the April 2014 issue of the Journal of Thoracic Oncology described the treatment success at Wake Forest Baptist.
“One of the toughest challenges of lung cancer is what to do for patients when the cancer comes back in an area that’s been treated previously with radiation treatment,” said James J. Urbanic, MD, lead author of the studies and a radiation oncologist at Wake Forest Baptist. “With some of the technological advances in radiation treatments that have occurred in the last 5 to 10 years, we’re beginning to re-look at the issue and ask—can we target the radiation precisely enough and with a high enough dose to knock the cancer back?”
According to Dr. Urbanic, the overall findings of the study suggest that there are some patients with recurrent lung tumors who can be treated with another definitive course of radiation therapy and still have a probability of a cure. “At many cancer treatment centers, these patients only get chemotherapy and have no chance at definitive treatment. The goal of treatment is solely to prevent or delay symptoms from developing and they are seen as incurable,” he said. “But with re-irradiation, our study shows that maybe we can give a curative intent treatment that we couldn’t do in the past. It’s a layer of hope for some patients that they never had before.”
The researchers reviewed 11 years of clinical research for the study. Eighty-six patients were identified who received at least two sequences of thoracic radiotherapy. Of that number, 33 were treated with repeat thoracic radiotherapy using stereotactic body radiation therapy (SBRT) or accelerated hypofractionated radiotherapy (AHRT), as a component of their treatment. The median age was 66 and the majority of patients (88%) were treated for primary lung cancer. The median tumor size at retreatment was 2.5 cm. Earlier lung resections had been performed in 24% of patients.
Dr. Urbanic noted that the typical patient is an older man or woman who got treated with either chemotherapy and radiation or radiation by itself for a lung cancer that could not be surgically removed. They have returned for a checkup and feel well, but a computed tomography (CT) scan shows that the cancer has returned in the area earlier treated. If the cancer is just in one area, the patients get retreated with 10 radiation treatments done with the SBRT technique which is tightly targeted to just the tumor and minimizes the dose to the neighboring healthy tissue.
“Wake Forest Baptist has been developing expertise in doing this,” Dr. Urbanic said. “We’re finding that there are patients who are alive years later. We have seen relatively modest toxicity and a good ability to try and control the disease upwards of 70% of the time.”
However, there is a higher risk of injury involved when someone is radiated a second time which is why other cancer treatment center programs might be reluctant to adopt the practice, Dr. Urbanic reported. “This is a fairly niche effort in lung cancer care, and we’d like to see a national level clinical trial at some point,” Dr. Urbanic said. “The technology has gotten to the point where I think it’s going to allow radiation oncologists to reassess their ability so that maybe they can take risks they weren’t willing to take before. Eventually, this practice will become more widespread.”
Related Links:
Comprehensive Cancer Center of Wake Forest Baptist Medical Center
Latest Nuclear Medicine News
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
- New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more